Let’s have more babies — and less of this
By Philip Bump,
The Washington Post
| 04. 24. 2025
My wife and I decided to have children for an entirely prosaic reason: We wanted to start a family. I’m glad every day that we did; my kids are the most important thing in my life. Literally the moment my oldest son was born, I became acutely aware of my own age and that a clock was ticking on the time I’d get to spend with him. I wished I’d had him sooner just to extend that duration, but I realize that no amount of time would be enough.
I am, in other words, an advocate of having children. I understand that parenting isn’t easy and that I am advantaged in doing so by having a partner and a steady income. I also understand that some people who want kids are unable to have them. What I do not understand, though, is the prevalent idea that having children is an essential element of reconstructing some idealized version of America — that having a clutch of kids is how we make America great again, in all of the ways that phrase...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...